We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $27.7B
1-Year Est. Return 22.98%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$3.71B
AUM Growth
-$2.38B
Cap. Flow
+$958M
Cap. Flow %
25.84%
Top 10 Hldgs %
16.45%
Holding
4,289
New
2,736
Increased
922
Reduced
516
Closed
32

Sector Composition

Rank Sector Weight
1 Technology 8.45%
2 Healthcare 6.22%
3 Financials 4.93%
4 Energy 3.58%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZUO
4051
DELISTED
Zuora, Inc.
ZUO
$1 ﹤0.01%
+90
New +$636
CNSL
4052
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$1 ﹤0.01%
+230
New +$1.02K
DNMR
4053
DELISTED
Danimer Scientific, Inc.
DNMR
$1 ﹤0.01%
+12
New +$1.14K
GTHX
4054
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1 ﹤0.01%
+200
New +$1.68K
ASXC
4055
DELISTED
Asensus Surgical, Inc.
ASXC
$1 ﹤0.01%
+2,000
New +$813
AINC
4056
DELISTED
Ashford Inc.
AINC
$1 ﹤0.01%
+49
New +$729
TGAN
4057
DELISTED
Transphorm, Inc. Common Stock
TGAN
$1 ﹤0.01%
+100
New +$588
EXPR
4058
DELISTED
Express, Inc.
EXPR
$1 ﹤0.01%
+50
New +$1.19K
MDVL
4059
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$1 ﹤0.01%
+60
New +$1.73K
NMRD
4060
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$1 ﹤0.01%
+360
New +$794
FATH
4061
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$1 ﹤0.01%
+37
New +$1.62K
CPUH
4062
DELISTED
Compute Health Acquisition Corp.
CPUH
$1 ﹤0.01%
+87
New +$870
BGRY
4063
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$1 ﹤0.01%
+1,300
New +$1.45K
PLXP
4064
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$1 ﹤0.01%
+4,300
New +$1.8K
AMYT
4065
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$1 ﹤0.01%
+171
New +$1.21K
EPHY
4066
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$1 ﹤0.01%
+135
New +$1.35K
CORZ
4067
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$1 ﹤0.01%
15,000
-100
-0.7% -$46
AVEO
4068
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1 ﹤0.01%
+50
New +$692
ADRE
4069
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$1 ﹤0.01%
+30
New +$1.08K
ABUS icon
4070
Arbutus Biopharma
ABUS
$871M
$0 ﹤0.01%
+10
New +$24
AEVA
4071
Aeva Technologies
AEVA
$1.13B
$0 ﹤0.01%
+60
New +$525
AGZD icon
4072
WisdomTree Trust WisdomTree Interest Rate Hedged US Aggregate Bond Fund
AGZD
$131M
$0 ﹤0.01%
+6
New +$135
AMBP icon
4073
Ardagh Metal Packaging
AMBP
$2.9B
$0 ﹤0.01%
+46
New +$211
AMPH icon
4074
Amphastar Pharmaceuticals
AMPH
$899M
$0 ﹤0.01%
+11
New +$319
AOUT icon
4075
American Outdoor Brands
AOUT
$158M
$0 ﹤0.01%
+25
New +$233

Similar funds

NewEdge Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, NewEdge Advisors held 4,289 positions worth $3.71B, down 39% from $6.09B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

NewEdge Advisors deployed $958M of net new capital in Q4 2022, opening 2,736 new positions and adding to 922 existing holdings. Its largest new stake was iShares Treasury Floating Rate Bond ETF: 214,050 shares worth $10.8M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Union Pacific, an estimated $25M trimmed.

  • NewEdge Advisors's largest Q4 2022 buy was iShares Treasury Floating Rate Bond ETF: 214,050 shares worth $10.8M.
  • NewEdge Advisors added most to iShares iBonds Dec 2024 Term Corporate ETF in Q4 2022, an estimated $37.6M increase.
  • NewEdge Advisors's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $25M.
  • NewEdge Advisors fully exited Duke Realty Corp. in Q4 2022, selling an estimated $28.1M.
  • NewEdge Advisors's ten largest holdings make up 16% of its $3.71B portfolio in Q4 2022.
  • NewEdge Advisors opened 2,736 new positions and closed 32 in Q4 2022.
  • NewEdge Advisors's portfolio value fell 39% quarter-over-quarter to $3.71B.

Based on NewEdge Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.